gene,baseMean,log2FoldChange,lfcSE,pvalue,padj,LOC_ID,transcript,database,uniprot_accession,geneID,species,pident,length,mismatch,gapopen,qstart,qend,sstart,send,evalue,bitscore,reviewed,entryname,protein_name,gene_name,organism,prot_length,GO_ID,GO_BP,GO_MF,GO_CC,Genename_orderedlocus,Induction,Pathwaycommons,Reactome,Unipathway,Interacts_with
gene-LOC134715138|LOC134715138,123.239971596392,0.671263677261227,0.222074767158526,1.15823431014394e-4,0.0159032653895767,LOC134715138,lcl|NC_086376.1_cds_XP_063433154.1_17770,sp,Q5ZM98,GRP75,CHICK,82.419,620,109,0,103,1962,39,658,0,1005,reviewed,GRP75_CHICK,"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)",HSPA9 RCJMB04_2m8,Gallus gallus (Chicken),675,GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0042026; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0140662; GO:1902037; GO:1903707,chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634],,,,,,
gene-LOC134708608|LOC134708608,87.5393755065314,-0.0995683444969049,0.193371924587855,1.54957348860497e-4,0.0193249031512247,LOC134708608,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134707955|LOC134707955,100.22639570784,1.29961276240365,0.203050561139556,7.99130366044577e-12,4.48471961424217e-8,LOC134707955,lcl|NC_086374.1_cds_XP_063424208.1_9669,sp,Q5RAE3,LAT2,PONAB,51.782,477,226,3,94,1512,34,510,1.42e-151,446,reviewed,LAT2_PONAB,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8),SLC7A8 LAT2,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),535,GO:0015175; GO:0015179; GO:0015297; GO:0015349; GO:0015804; GO:0016323; GO:0046982; GO:0070327,neutral amino acid transport [GO:0015804]; thyroid hormone transport [GO:0070327],antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; protein heterodimerization activity [GO:0046982]; thyroid hormone transmembrane transporter activity [GO:0015349],basolateral plasma membrane [GO:0016323],,,,,,
gene-LOC134715827|LOC134715827,36.0683649226507,0.571461801920706,0.230254445214607,6.21785987153496e-4,0.0453177007779924,LOC134715827,lcl|NC_086376.1_cds_XP_063434383.1_19277,sp,Q66L33,MK16A,XENLA,81.183,186,34,1,1,555,1,186,2.26e-103,306,reviewed,MK16A_XENLA,Protein MAK16 homolog A (MAK16-like protein A),mak16-a mak16l-a,Xenopus laevis (African clawed frog),301,GO:0000460; GO:0000470; GO:0005730; GO:0030687,maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470],,"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]",,,,,,
gene-LOC134682960|LOC134682960,27.1597078091951,1.19261877841137,0.406111592371521,1.19019448745941e-4,0.0159032653895767,LOC134682960,lcl|NC_086381.1_cds_XP_063397978.1_35905,sp,Q15822,ACHA2,HUMAN,33.668,199,119,4,112,681,69,263,3.87e-30,122,reviewed,ACHA2_HUMAN,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Homo sapiens (Human),529,GO:0005654; GO:0005886; GO:0005892; GO:0006811; GO:0007165; GO:0007271; GO:0015464; GO:0016020; GO:0022848; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0095500; GO:0098828; GO:0120111; GO:1901363,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transport [GO:0006811]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],acetylcholine-gated channel complex [GO:0005892]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],,,Q15822;,R-HSA-629594;R-HSA-629597;,,
gene-LOC134685659|LOC134685659,37.5576915613065,0.913939770764734,0.256953263877103,1.65196252671367e-5,0.00487937563153532,LOC134685659,lcl|NC_086381.1_cds_XP_063401685.1_35685,sp,Q9P2J5,SYLC,HUMAN,62.5,1176,426,7,31,3519,2,1175,0,1472,reviewed,SYLC_HUMAN,"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) (cLRS)",LARS1 KIAA1352 LARS,Homo sapiens (Human),1176,GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253,cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604],,,Q9P2J5;,R-HSA-2408522;R-HSA-379716;R-HSA-9856649;,,P54136; Q8N122; Q9NQL2
gene-LOC134715512|LOC134715512,324.003490883297,-0.909766872736313,0.24677462056196,9.97570886570999e-6,0.00329315753849203,LOC134715512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134685237|LOC134685237,33.4182583042105,0.856952254618373,0.343778527651116,4.56194698998981e-4,0.0388473240862746,LOC134685237,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134696006|LOC134696006,63.9793838567961,0.542969956844833,0.208174036038936,4.57750639984029e-4,0.0388473240862746,LOC134696006,lcl|NC_086386.1_cds_XP_063413599.1_49978,sp,P35565,CALX,RAT,63.715,463,162,3,169,1557,68,524,2.76e-178,520,reviewed,CALX_RAT,Calnexin,Canx,Rattus norvegicus (Rat),591,GO:0005509; GO:0005783; GO:0005789; GO:0005790; GO:0005840; GO:0006457; GO:0016020; GO:0030246; GO:0030424; GO:0031965; GO:0031966; GO:0032839; GO:0032991; GO:0033162; GO:0034185; GO:0035255; GO:0036503; GO:0043025; GO:0043197; GO:0044233; GO:0044322; GO:0045202; GO:0045211; GO:0048488; GO:0048787; GO:0051082; GO:0072583; GO:0098793; GO:0098978,clathrin-dependent endocytosis [GO:0072583]; ERAD pathway [GO:0036503]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488],apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; unfolded protein binding [GO:0051082],axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; glutamatergic synapse [GO:0098978]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; smooth endoplasmic reticulum [GO:0005790]; synapse [GO:0045202],,,,R-RNO-2132295;R-RNO-8984722;R-RNO-901042;R-RNO-9020956;R-RNO-983170;,,
gene-LOC134685076|LOC134685076,20.2446689637964,-0.823747149513518,0.270903568518299,9.93933127024268e-5,0.0159032653895767,LOC134685076,lcl|NC_086381.1_cds_XP_063400550.1_34179,sp,Q3UVU3,ZNT10,MOUSE,38.313,415,220,9,1,1149,1,411,2.19e-90,284,reviewed,ZNT10_MOUSE,Calcium/manganese antiporter SLC30A10 (Solute carrier family 30 member 10),Slc30a10,Mus musculus (Mouse),470,GO:0000139; GO:0005385; GO:0005794; GO:0005886; GO:0006828; GO:0006882; GO:0007173; GO:0010312; GO:0016020; GO:0030026; GO:0031901; GO:0055038; GO:0055071; GO:0062111; GO:0070374; GO:0071577; GO:0140048; GO:0140983; GO:1904385,cellular response to angiotensin [GO:1904385]; detoxification of zinc ion [GO:0010312]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular manganese ion homeostasis [GO:0030026]; intracellular zinc ion homeostasis [GO:0006882]; manganese ion export across plasma membrane [GO:0140048]; manganese ion homeostasis [GO:0055071]; manganese ion transport [GO:0006828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577],calcium:manganese antiporter activity [GO:0140983]; zinc ion transmembrane transporter activity [GO:0005385],early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],,,,R-MMU-425410;,,Q2HJ10
gene-LOC134714372|LOC134714372,47.6813144566492,0.618563777320171,0.19775770065247,8.84664646183574e-5,0.0159032653895767,LOC134714372,lcl|NC_086373.1_cds_XP_063431687.1_412,sp,A4FV45,TM214,BOVIN,30.551,563,368,9,7,1656,6,558,6.88e-78,265,reviewed,TM214_BOVIN,Transmembrane protein 214,TMEM214,Bos taurus (Bovine),687,GO:0005783; GO:0005789; GO:0005794; GO:0005881; GO:0006915,apoptotic process [GO:0006915],,cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],,,,,,
gene-LOC134717170|LOC134717170,230.955508293766,0.280847864770836,0.0840498551504873,1.16294499081079e-4,0.0159032653895767,LOC134717170,lcl|NC_086373.1_cds_XP_063436034.1_921,sp,Q9JIH7,WNK1,RAT,72.778,360,97,1,886,1965,204,562,1.75e-168,573,reviewed,WNK1_RAT,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1),Wnk1 Hsn2 Prkwnk1,Rattus norvegicus (Rat),2126,GO:0000287; GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0006884; GO:0007165; GO:0007507; GO:0008217; GO:0010507; GO:0010766; GO:0010793; GO:0010820; GO:0016020; GO:0019870; GO:0019901; GO:0019902; GO:0030291; GO:0030295; GO:0030644; GO:0031397; GO:0032991; GO:0033633; GO:0034115; GO:0035556; GO:0035725; GO:0038116; GO:0043232; GO:0045050; GO:0045766; GO:0050801; GO:0050804; GO:0050852; GO:0055075; GO:0055080; GO:0071277; GO:0071474; GO:0072686; GO:0090188; GO:0090263; GO:0097022; GO:0098982; GO:0106310; GO:0140693; GO:0140694; GO:1902305; GO:1903038; GO:1903077; GO:1903288; GO:1903490; GO:1904062; GO:1904595; GO:1990869,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; heart development [GO:0007507]; intracellular chloride ion homeostasis [GO:0030644]; intracellular signal transduction [GO:0035556]; lymphocyte migration into lymph node [GO:0097022]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic cation homeostasis [GO:0055080]; monoatomic ion homeostasis [GO:0050801]; monoatomic ion transport [GO:0006811]; negative regulation of autophagy [GO:0010507]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transport [GO:0010766]; non-membrane-bounded organelle assembly [GO:0140694]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; potassium ion homeostasis [GO:0055075]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of mRNA export from nucleus [GO:0010793]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; molecular condensate scaffold activity [GO:0140693]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291],cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; intracellular non-membrane-bounded organelle [GO:0043232]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],,,,,,P29101
gene-LOC134717170|LOC134717170,230.955508293766,0.280847864770836,0.0840498551504873,1.16294499081079e-4,0.0159032653895767,LOC134717170,lcl|NC_086373.1_cds_XP_063436036.1_923,sp,Q80XP9,WNK3,MOUSE,48.879,669,310,13,910,2889,137,782,9.45e-172,575,reviewed,WNK3_MOUSE,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Wnk3,Mus musculus (Mouse),1757,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010766; GO:0010800; GO:0018107; GO:0019870; GO:0032414; GO:0035556; GO:0035633; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:1903077; GO:1903078; GO:1903288; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; intracellular signal transduction [GO:0035556]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of sodium ion transport [GO:0010766]; non-membrane-bounded organelle assembly [GO:0140694]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829],,,,,,
gene-LOC134720801|LOC134720801,125.374756265719,0.625881953548877,0.11542996124687,3.5309698614518e-9,6.6052676208225e-6,LOC134720801,lcl|NC_086378.1_cds_XP_063439383.1_23549,sp,Q7YR26,TOP1,CHLAE,73.022,556,150,0,1282,2949,212,767,0,847,reviewed,TOP1_CHLAE,DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I),TOP1,Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops),767,GO:0000978; GO:0003677; GO:0003682; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0032922,chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; DNA replication [GO:0006260]; DNA topological change [GO:0006265],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,,,,,
gene-LOC134685357|LOC134685357,75.3945236051017,0.429417834680832,0.156104813629686,3.88759371279746e-4,0.0357658621577366,LOC134685357,lcl|NC_086381.1_cds_XP_063401122.1_34913,sp,Q9EPL8,IPO7,MOUSE,56.798,1037,439,6,1,3102,1,1031,0,1205,reviewed,IPO7_MOUSE,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),Ipo7 Ranbp7,Mus musculus (Mouse),1038,GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331,innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606],histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,INDUCTION: Induced by odontoblastic differentiation in dental papilla cells. {ECO:0000269|PubMed:35922041}.,,,,
gene-LOC134725463|LOC134725463,30.130646720416,0.505621320808453,0.193775328435644,5.05452703716086e-4,0.041110153235575,LOC134725463,lcl|NC_086379.1_cds_XP_063445364.1_29573,sp,Q0V8S0,HGS,BOVIN,53.796,619,233,11,16,1752,5,610,1.05e-170,514,reviewed,HGS_BOVIN,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,Bos taurus (Bovine),777,GO:0005769; GO:0015031; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0035091; GO:0043130; GO:0046872,endocytic recycling [GO:0032456]; protein transport [GO:0015031]; receptor internalization [GO:0031623],metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; multivesicular body membrane [GO:0032585],,,,R-BTA-182971;R-BTA-432720;R-BTA-5689880;R-BTA-6807004;R-BTA-8856825;R-BTA-8856828;R-BTA-9013420;R-BTA-917729;R-BTA-9706019;,,
STRG.11120|LOC134697233,45.5807271478055,-1.33499746918401,0.453157875615624,1.09267923826011e-4,0.0159032653895767,LOC134697233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134706837|LOC134706837,354.022552952408,0.285138798151629,0.098795037362734,4.95306172095488e-4,0.0408773270264688,LOC134706837,lcl|NC_086374.1_cds_XP_063422216.1_7213,sp,Q13439,GOGA4,HUMAN,28.291,714,448,12,1,2079,1,671,9.3e-50,200,reviewed,GOGA4_HUMAN,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),GOLGA4,Homo sapiens (Human),2230,GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0016192; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020; GO:0070062,Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192],GTPase binding [GO:0051020]; small GTPase binding [GO:0031267],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],,,Q13439;,R-HSA-6811440;R-HSA-9673768;,,Q96NW4
STRG.1759|LOC134706618,31.4126890135475,1.57881462958615,0.687838395560535,5.87625768918422e-4,0.04456426777257,LOC134706618,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134712116|LOC134712116,24.2075755442845,-1.33571861778765,0.571000123083489,5.43438543564509e-4,0.0423580153678337,LOC134712116,lcl|NC_086375.1_cds_XP_063429358.1_14336,sp,Q2KJ64,ARGI1,BOVIN,56.23,313,133,3,16,948,4,314,5.95e-121,353,reviewed,ARGI1_BOVIN,Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase),ARG1,Bos taurus (Bovine),322,GO:0000050; GO:0004053; GO:0005737; GO:0005829; GO:0019547; GO:0030145,arginine catabolic process to ornithine [GO:0019547]; urea cycle [GO:0000050],arginase activity [GO:0004053]; manganese ion binding [GO:0030145],cytoplasm [GO:0005737]; cytosol [GO:0005829],,,,R-BTA-6798695;R-BTA-70635;,UPA00158;,
gene-LOC134715738|LOC134715738,16.3957315769424,-0.853297108584471,0.27053070380277,7.20455080659873e-5,0.0159032653895767,LOC134715738,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134714775|LOC134714775,76.3363192624625,0.399148891676268,0.145205986017483,4.33269302654854e-4,0.0388473240862746,LOC134714775,lcl|NC_086376.1_cds_XP_063432396.1_16898,sp,O00566,MPP10,HUMAN,48.096,499,214,9,628,2037,199,681,1.33e-60,218,reviewed,MPP10_HUMAN,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),MPHOSPH10 MPP10,Homo sapiens (Human),681,GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006396; GO:0008380; GO:0030490; GO:0032040; GO:0034457; GO:0042274,"maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",RNA binding [GO:0003723],chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],,,O00566;,R-HSA-6790901;R-HSA-6791226;,,Q13895; Q9UI47-2; Q9NV31; Q96G21; Q9UBU8-2; P62136; PRO_0000449626 [P0DTD1]
gene-LOC134722878|LOC134722878,249.745146662669,-1.46040584813903,0.553929670250349,2.52954539023528e-4,0.0283916174600008,LOC134722878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134705220|LOC134705220,14.7752440644518,-1.11485197905119,0.431735867964108,3.30339968122851e-4,0.0333199071790098,LOC134705220,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134714939|LOC134714939,245.353511199236,0.663733115371251,0.138187267073258,9.03511757792636e-8,8.45084664122045e-5,LOC134714939,lcl|NC_086376.1_cds_XP_063432732.1_17314,sp,Q9D0R2,SYTC,MOUSE,69.481,675,203,1,133,2148,45,719,0,1032,reviewed,SYTC_MOUSE,"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)",Tars1 Tars,Mus musculus (Mouse),722,GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802,threonyl-tRNA aminoacylation [GO:0006435],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737],,,,,,
gene-LOC134723546|LOC134723546,133.812889642952,-0.0646118963054502,0.149924657154827,1.03985195028955e-4,0.0159032653895767,LOC134723546,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134696622|LOC134696622,271.883831521628,0.375295618018213,0.131182569550621,3.41700941588265e-4,0.0333199071790098,LOC134696622,lcl|NC_086386.1_cds_XP_063414562.1_48941,sp,O60841,IF2P,HUMAN,70.358,614,182,0,1867,3708,607,1220,0,936,reviewed,IF2P_HUMAN,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),EIF5B IF2 KIAA0741,Homo sapiens (Human),1220,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],,,O60841;,R-HSA-72706;,,O14602; P14921; P28799; O43933; O76024
gene-LOC134707842|LOC134707842,28.6807108725326,0.52971738921213,0.20732796342849,5.35496936933787e-4,0.0423580153678337,LOC134707842,lcl|NC_086374.1_cds_XP_063423999.1_9398,sp,Q6PF21,SYMC,XENLA,52.987,904,393,7,7,2706,1,876,0,937,reviewed,SYMC_XENLA,"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)",mars1 mars,Xenopus laevis (African clawed frog),905,GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005829; GO:0006431; GO:0017101,methionyl-tRNA aminoacylation [GO:0006431],ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleolus [GO:0005730],,,,,,
gene-LOC134710226|LOC134710226,249.619712585543,0.545331233772226,0.188581160354085,2.03088117857808e-4,0.0242495854769791,LOC134710226,lcl|NC_086375.1_cds_XP_063426549.1_11628,sp,P59325,IF5,MOUSE,53.81,420,178,4,7,1263,2,406,3.06e-129,383,reviewed,IF5_MOUSE,Eukaryotic translation initiation factor 5 (eIF-5),Eif5,Mus musculus (Mouse),429,GO:0001731; GO:0001732; GO:0003743; GO:0005092; GO:0005096; GO:0005525; GO:0005829; GO:0005886; GO:0006446; GO:0042255; GO:0045202; GO:0071074,formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255],eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; translation initiation factor activity [GO:0003743],cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202],,,,R-MMU-72702;R-MMU-72706;,,
gene-LOC134721830|LOC134721830,204.052452957997,-0.471173515632152,0.170956615672557,3.46102898908022e-4,0.0333199071790098,LOC134721830,lcl|NC_086378.1_cds_XP_063441147.1_26182,sp,P41044,CAB32,DROME,61.017,295,114,1,16,897,15,309,9.72e-118,344,reviewed,CAB32_DROME,Calbindin-32,Cbp53E cbn CG6702,Drosophila melanogaster (Fruit fly),310,GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043195; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271,regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],calcium ion binding [GO:0005509],cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467],,,,,,
gene-LOC134691227|LOC134691227,151.293305674739,1.27149918833662,0.334971850723134,6.03889587881944e-6,0.00242073454799534,LOC134691227,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134721786|LOC134721786,37.0990153236598,0.490779021993745,0.196834246927245,6.71678057390549e-4,0.0482917380279505,LOC134721786,lcl|NC_086373.1_cds_XP_063441073.1_1701,sp,Q6AXX4,SAS10,RAT,36.605,489,249,9,85,1530,36,470,1.08e-58,204,reviewed,SAS10_RAT,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Disrupter of silencing SAS10) (UTP3 homolog),Utp3 Crlz1 Sas10,Rattus norvegicus (Rat),470,GO:0000462; GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040; GO:0042274,"brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]",,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],,,,R-RNO-6791226;,,
gene-LOC134714791|LOC134714791,177.429668033943,0.750444902000455,0.19202881775205,4.70653946706405e-6,0.0020317768837818102,LOC134714791,lcl|NC_086376.1_cds_XP_063432422.1_16928,sp,Q2KJG3,SYNC,BOVIN,67.096,544,178,1,22,1653,17,559,0,766,reviewed,SYNC_BOVIN,"Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)",NARS,Bos taurus (Bovine),559,GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0006421,asparaginyl-tRNA aminoacylation [GO:0006421],asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676],cytoplasm [GO:0005737],,,,,,
gene-LOC134710563|LOC134710563,28.6407492835114,-0.0204927837019259,0.12494907083081,1.61958950363593e-4,0.0197589919443584,LOC134710563,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134715868|LOC134715868,83.8294890439731,0.449998995463568,0.157656390628325,2.77384972509495e-4,0.0305232248181036,LOC134715868,lcl|NC_086376.1_cds_XP_063434464.1_19365,sp,Q7SXU0,EI3JA,DANRE,44.845,194,95,4,4,549,4,197,7.64e-32,120,reviewed,EI3JA_DANRE,Eukaryotic translation initiation factor 3 subunit J-A (eIF3j-A) (Eukaryotic translation initiation factor 3 subunit 1-A) (eIF-3-alpha-A) (eIF3 p35-A),eif3ja eif3j eif3s1a zgc:63801,Danio rerio (Zebrafish) (Brachydanio rerio),249,GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290,formation of cytoplasmic translation initiation complex [GO:0001732],translation initiation factor activity [GO:0003743],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],,,,R-DRE-156827;R-DRE-72689;R-DRE-72695;R-DRE-72702;,,
gene-LOC134725490|LOC134725490,28.4865123765378,-0.76397144586072,0.317962294289111,6.06595103521564e-4,0.0453177007779924,LOC134725490,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134715632|LOC134715632,27.7464255130158,-0.824474128499248,0.271928139156175,1.03353293957115e-4,0.0159032653895767,LOC134715632,lcl|NC_086376.1_cds_XP_063434018.1_18786,sp,O02485,YDJ1,CAEEL,36.628,344,177,7,37,1056,11,317,2.69e-73,234,reviewed,YDJ1_CAEEL,Uncharacterized protein ZK1073.1,ZK1073.1,Caenorhabditis elegans,325,GO:0005737; GO:0007165,signal transduction [GO:0007165],,cytoplasm [GO:0005737],,,,,,
gene-LOC134699002|LOC134699002,114.099753742089,0.278097318914068,0.0950665142326047,4.63786656054953e-4,0.0388473240862746,LOC134699002,lcl|NW_026963290.1_cds_XP_063416760.1_50461,sp,P23128,DDX6,DROME,81.188,404,76,0,79,1290,29,432,0,702,reviewed,DDX6_DROME,ATP-dependent RNA helicase me31b (EC 3.6.4.13) (Maternal expression at 31B),me31B CG4916,Drosophila melanogaster (Fruit fly),459,GO:0000290; GO:0000900; GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005783; GO:0007279; GO:0010494; GO:0016887; GO:0017148; GO:0030707; GO:0031087; GO:0033962; GO:0034063; GO:0035195; GO:0035278; GO:0036464; GO:0043025; GO:0043186; GO:0046959; GO:0050688; GO:0060148; GO:0061014; GO:0071598; GO:0071683; GO:0090328; GO:0098794; GO:0150011; GO:2000766,deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; follicle cell of egg chamber development [GO:0030707]; habituation [GO:0046959]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; pole cell formation [GO:0007279]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of post-transcriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683],,,,R-DME-430039;,,Q9VMA3; P48598; Q9VSG1
gene-LOC134720658|LOC134720658,57.4384865455161,-0.561130209781452,0.207519823837198,3.40489814154122e-4,0.0333199071790098,LOC134720658,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134706812|LOC134706812,159.331400708106,0.348383313495399,0.130936195353212,6.79801729188898e-4,0.0482917380279505,LOC134706812,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134706577|LOC134706577,39.5566611191074,0.790612679813988,0.254378986453383,8.19685026962054e-5,0.0159032653895767,LOC134706577,lcl|NC_086374.1_cds_XP_063421696.1_6618,sp,Q5DC69,CH10,SCHJA,65.657,99,34,0,4,300,3,101,4.74e-43,139,reviewed,CH10_SCHJA,"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10)",SJCHGC01960 SJCHGC09469,Schistosoma japonicum (Blood fluke),102,GO:0005524; GO:0005759; GO:0044183; GO:0046872; GO:0051082; GO:0051085; GO:0051087,chaperone cofactor-dependent protein refolding [GO:0051085],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],mitochondrial matrix [GO:0005759],,,,,,
gene-LOC134706577|LOC134706577,39.5566611191074,0.790612679813988,0.254378986453383,8.19685026962054e-5,0.0159032653895767,LOC134706577,lcl|NC_086374.1_cds_XP_063421697.1_6619,sp,Q9W6X3,CH10,ORYLA,65.169,89,31,0,1,267,9,97,8.21e-38,125,reviewed,CH10_ORYLA,"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10)",hspe1 hsp10,Oryzias latipes (Japanese rice fish) (Japanese killifish),99,GO:0005524; GO:0005759; GO:0044183; GO:0046872; GO:0051082; GO:0051085; GO:0051087,chaperone cofactor-dependent protein refolding [GO:0051085],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],mitochondrial matrix [GO:0005759],,,,,,
gene-LOC134693708|LOC134693708,22.8896497716033,0.683613282053041,0.218449908653275,8.43260644310162e-5,0.0159032653895767,LOC134693708,lcl|NC_086384.1_cds_XP_063410681.1_44169,sp,Q5XIH7,PHB2,RAT,72.727,264,67,2,109,885,36,299,1.32e-140,401,reviewed,PHB2_RAT,Prohibitin-2 (B-cell receptor-associated protein BAP37) (BAP-37),Phb2 Bcap37,Rattus norvegicus (Rat),299,GO:0000423; GO:0002639; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006606; GO:0007005; GO:0007062; GO:0007202; GO:0009986; GO:0014069; GO:0016363; GO:0016477; GO:0023035; GO:0030520; GO:0031536; GO:0032991; GO:0033147; GO:0033218; GO:0033598; GO:0033600; GO:0035632; GO:0039529; GO:0042113; GO:0042802; GO:0042803; GO:0043066; GO:0045892; GO:0046625; GO:0046982; GO:0048786; GO:0050821; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098800; GO:0098978; GO:0098982; GO:0140374; GO:1900208; GO:1901224; GO:1902808; GO:1904959; GO:1990051,activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; intracellular estrogen receptor signaling pathway [GO:0030520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mammary gland epithelial cell proliferation [GO:0033598]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062],amide binding [GO:0033218]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625],cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991],,,,R-RNO-8949664;R-RNO-9840373;,,
gene-LOC134706345|LOC134706345,69.3710572458194,0.67716111457221,0.196296738835088,2.81262411252953e-5,0.00726367731153907,LOC134706345,lcl|NC_086374.1_cds_XP_063421275.1_6133,sp,P41250,GARS,HUMAN,63.744,673,242,2,190,2202,61,733,0,932,reviewed,GARS_HUMAN,Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1),GARS1 GARS,Homo sapiens (Human),739,GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150,diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141],,,P41250;,R-HSA-379716;R-HSA-379726;,,Q16520; Q9UNS2; P41250; Q99612; Q9BR81; Q8WXH5; Q99932-2; Q9CZD3
gene-LOC134720845|LOC134720845,26.3867800129801,0.537722787548013,0.18855862232891,2.43415793187781e-4,0.027878559823874,LOC134720845,lcl|NC_086378.1_cds_XP_063439475.1_23658,sp,Q14684,RRP1B,HUMAN,38.739,333,173,5,34,948,8,337,1.24e-59,218,reviewed,RRP1B_HUMAN,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),RRP1B KIAA0179,Homo sapiens (Human),758,GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586,apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],"chromosome [GO:0005694]; cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]",,INDUCTION: By DNA damage. {ECO:0000269|PubMed:20040599}.,Q14684;,,,Q01094; P22087; P62136; P62140; P36873; P61353; P46777; P56182; Q07955; P62805; P09874
gene-LOC134687008|LOC134687008,54.9468684205917,0.731774271400108,0.227819871970578,6.08431732380189e-5,0.0142271620088234,LOC134687008,lcl|NC_086382.1_cds_XP_063402987.1_37973,sp,F1QGW6,IF2G,DANRE,85.201,473,69,1,1,1419,1,472,0,824,reviewed,IF2G_DANRE,Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma) (eIF2-gamma),eif2s3,Danio rerio (Zebrafish) (Brachydanio rerio),472,GO:0001731; GO:0002183; GO:0003743; GO:0003924; GO:0005525; GO:0005829; GO:0005850; GO:1990856,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; methionyl-initiator methionine tRNA binding [GO:1990856]; translation initiation factor activity [GO:0003743],cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850],,,,R-DRE-156827;R-DRE-382556;R-DRE-72695;R-DRE-72702;R-DRE-72731;R-DRE-9840373;,,
gene-LOC134721016|LOC134721016,319.767594312413,-0.548325100329379,0.172821822343166,8.31408215395228e-5,0.0159032653895767,LOC134721016,lcl|NC_086378.1_cds_XP_063439738.1_24078,sp,Q96MT7,CFA44,HUMAN,43.094,1752,944,15,784,5937,105,1837,0,1160,reviewed,CFA44_HUMAN,Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52),CFAP44 WDR52,Homo sapiens (Human),1854,GO:0000226; GO:0005737; GO:0005856; GO:0007288; GO:0008233; GO:0031514,microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288],peptidase activity [GO:0008233],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],,,Q96MT7;,,,O95257
gene-LOC134724433|LOC134724433,77.244396693109607,0.475566639958328,0.154498725101106,1.31393570593965e-4,0.0171483887947286,LOC134724433,lcl|NC_086373.1_cds_XP_063443530.1_2062,sp,Q21086,GNL3,CAEEL,48.491,464,215,8,22,1380,7,457,1.39e-130,397,reviewed,GNL3_CAEEL,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),nst-1 K01C8.9,Caenorhabditis elegans,556,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],GTP binding [GO:0005525]; GTPase activity [GO:0003924],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,,,R-CEL-6791226;,,
gene-LOC134720381|LOC134720381,43.3251008511403,0.40381930135474,0.147271050220362,4.44513367944163e-4,0.0388473240862746,LOC134720381,lcl|NC_086373.1_cds_XP_063438902.1_1415,sp,Q6NWJ4,DNJC2,DANRE,51.55,613,281,6,55,1875,1,603,3.51e-158,471,reviewed,DNJC2_DANRE,DnaJ homolog subfamily C member 2,dnajc2 zgc:85671,Danio rerio (Zebrafish) (Brachydanio rerio),618,GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649,'de novo' cotranslational protein folding [GO:0051083]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450],chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649],cytosol [GO:0005829]; nucleus [GO:0005634],,,,R-DRE-3371453;,,
gene-LOC134697178|LOC134697178,24.2951193556559,-0.673857981254126,0.272006942524294,5.42386021643974e-4,0.0423580153678337,LOC134697178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134722124|LOC134722124,492.560451838995,0.950929297848388,0.23706558299771,2.77856801580703e-6,0.00129944364205909,LOC134722124,lcl|NC_086378.1_cds_XP_063441737.1_26898,sp,Q0VA61,HYOU1,XENTR,55.738,549,236,3,79,1716,24,568,0,547,reviewed,HYOU1_XENTR,Hypoxia up-regulated protein 1,hyou1 hsph4,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),643,GO:0005524; GO:0005788; GO:0140662,,ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],endoplasmic reticulum lumen [GO:0005788],,,,,,
gene-LOC134715180|LOC134715180,71.4159212636193,0.521703868521056,0.139565674606728,1.15484149694941e-5,0.00360053915604448,LOC134715180,lcl|NC_086376.1_cds_XP_063433257.1_17887,sp,O00567,NOP56,HUMAN,72.893,439,113,2,10,1314,3,439,0,652,reviewed,NOP56_HUMAN,Nucleolar protein 56 (Nucleolar protein 5A),NOP56 NOL5A,Homo sapiens (Human),594,GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0045296; GO:0070761; GO:1990226,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515],box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],,,O00567;,R-HSA-390471;R-HSA-6790901;R-HSA-6791226;,,Q9H190
gene-LOC134685572|LOC134685572,18.7550803030812,0.871819478834992,0.29778767226193,1.42592470722974e-4,0.0181870214931212,LOC134685572,lcl|NC_086381.1_cds_XP_063401455.1_35404,sp,Q8K2D0,F199X,MOUSE,34.197,193,93,6,184,693,71,252,9.17e-22,97.8,reviewed,F199X_MOUSE,Protein FAM199X,Fam199x,Mus musculus (Mouse),388,,,,,,,,,,
gene-LOC134691224|LOC134691224,129.184101625925,1.12702590980046,0.279272506270606,2.41863000282769e-6,0.00123394105235173,LOC134691224,lcl|NC_086383.1_cds_XP_063407654.1_42253,sp,Q8BL74,TF3C2,MOUSE,29.928,558,329,19,2374,3909,322,863,2.93e-54,209,reviewed,TF3C2_MOUSE,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),Gtf3c2 Kiaa0011,Mus musculus (Mouse),907,GO:0000127; GO:0005634; GO:0006383,transcription by RNA polymerase III [GO:0006383],,nucleus [GO:0005634]; transcription factor TFIIIC complex [GO:0000127],,,,R-MMU-76061;R-MMU-76066;,,
gene-LOC134705633|LOC134705633,22.3376154239444,1.68696057243071,0.403124454876453,1.15856224423022e-6,6.50185131461997e-4,LOC134705633,lcl|NC_086374.1_cds_XP_063420423.1_6721,sp,Q5ZJU3,ASNS,CHICK,62.26,469,170,3,1,1386,88,556,0,555,reviewed,ASNS_CHICK,Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase),ASNS RCJMB04_15l3,Gallus gallus (Chicken),561,GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0042149; GO:0043066; GO:0045931; GO:0070981,asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931],asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524],cytosol [GO:0005829],,,,,UPA00134;,
gene-LOC134714997|LOC134714997,32.8095430222586,-0.511745322894078,0.188101730174995,3.59095929199379e-4,0.0335874392444486,LOC134714997,lcl|NC_086376.1_cds_XP_063432879.1_17467,sp,O94844,RHBT1,HUMAN,35.725,669,373,7,25,1872,9,673,3.96e-111,353,reviewed,RHBT1_HUMAN,Rho-related BTB domain-containing protein 1,RHOBTB1 KIAA0740,Homo sapiens (Human),696,GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007015; GO:0007163; GO:0010008; GO:0019901; GO:0032488,actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],,,O94844;,R-HSA-9013422;,,Q92993; Q8TAP4-4; P17252; O60260-5; Q15047-2; P61981
gene-LOC134696498|LOC134696498,31.7847198993296,-1.18876801686801,0.466600763176438,3.50298382673126e-4,0.0333199071790098,LOC134696498,lcl|NC_086386.1_cds_XP_063414401.1_49730,sp,Q28039,SC6A9,BOVIN,45.853,639,291,12,7,1899,25,616,4.16e-159,475,reviewed,SC6A9_BOVIN,Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9),SLC6A9,Bos taurus (Bovine),638,GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0045202; GO:0060012; GO:0060092; GO:1903804,"glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012]",glycine:sodium symporter activity [GO:0015375],plasma membrane [GO:0005886]; synapse [GO:0045202],,,,,,
gene-LOC134706457|LOC134706457,87.8270872816828,0.498841091899292,0.1442257374096,3.54999313464843e-5,0.00866198324854217,LOC134706457,lcl|NC_086374.1_cds_XP_063421479.1_6361,sp,O42254,IF2B1,CHICK,29.711,589,307,12,1,1545,1,556,4.58e-69,236,reviewed,IF2B1_CHICK,Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1),IGF2BP1 VICKZ1 ZBP1,Gallus gallus (Chicken),576,GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007399; GO:0010494; GO:0010976; GO:0017148; GO:0030027; GO:0030175; GO:0030426; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:1990247,CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976],mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247],CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471],,,,,,
gene-LOC134706457|LOC134706457,87.8270872816828,0.498841091899292,0.1442257374096,3.54999313464843e-5,0.00866198324854217,LOC134706457,lcl|NC_086374.1_cds_XP_063421476.1_6363,sp,Q5RB68,IF2B2,PONAB,36.86,586,300,11,1,1704,2,535,1.03e-96,309,reviewed,IF2B2_PONAB,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),IGF2BP2 VICKZ2,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),556,GO:0000932; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006417; GO:0007399; GO:0010494; GO:0048027; GO:0051028; GO:0070934; GO:1990247,CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of translation [GO:0006417],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],,,,,,
gene-LOC134706576|LOC134706576,85.5935554233208,0.922513454851223,0.187305429173203,4.3028224255175e-8,4.82948789040085e-5,LOC134706576,lcl|NC_086374.1_cds_XP_063421695.1_6617,sp,Q5ZL72,CH60,CHICK,75.226,553,135,1,1,1653,1,553,0,828,reviewed,CH60_CHICK,"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60)",HSPD1 HSP60 RCJMB04_7g5,Gallus gallus (Chicken),573,GO:0001530; GO:0002039; GO:0002755; GO:0002842; GO:0003725; GO:0005524; GO:0005737; GO:0005743; GO:0005759; GO:0005769; GO:0005829; GO:0005905; GO:0006457; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016853; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0034186; GO:0034514; GO:0042026; GO:0042100; GO:0042110; GO:0043025; GO:0043032; GO:0043065; GO:0043066; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051087; GO:0051702; GO:0070062; GO:0097225; GO:0097524; GO:0098761; GO:0140494; GO:0140662,apoptotic mitochondrial changes [GO:0008637]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to interleukin-7 [GO:0098761]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of type II interferon production [GO:0032729]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; T cell activation [GO:0042110],apolipoprotein A-I binding [GO:0034186]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; double-stranded RNA binding [GO:0003725]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625],cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lipopolysaccharide receptor complex [GO:0046696]; migrasome [GO:0140494]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524],,,,R-GGA-1268020;R-GGA-9837999;,,Q8AYS8
gene-LOC134721501|LOC134721501,45.6451984339643,0.807500727191299,0.236056615128703,2.84748576004739e-5,0.00726367731153907,LOC134721501,lcl|NC_086378.1_cds_XP_063440634.1_25377,sp,Q99MN1,SYK,MOUSE,68.142,565,171,3,4,1671,13,577,0,777,reviewed,SYK_MOUSE,Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS),Kars1 Kars,Mus musculus (Mouse),595,GO:0000049; GO:0002276; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0010165; GO:0015966; GO:0016597; GO:0017101; GO:0043032; GO:0045893; GO:0070371; GO:0097110,basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of macrophage activation [GO:0043032]; response to X-ray [GO:0010165],amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,,,R-MMU-9856649;,,
gene-LOC134683381|LOC134683381,159.729056317407,-0.694824421693478,0.181513435109896,6.70838090841731e-6,0.00250982891053586,LOC134683381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134721207|LOC134721207,88.0620956308685,1.18759713972172,0.268142202623645,4.20421827621603e-7,2.69579826416903e-4,LOC134721207,lcl|NC_086378.1_cds_XP_063440082.1_24664,sp,Q5RAE3,LAT2,PONAB,56.187,493,201,4,10,1449,9,499,2.5e-166,483,reviewed,LAT2_PONAB,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8),SLC7A8 LAT2,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),535,GO:0015175; GO:0015179; GO:0015297; GO:0015349; GO:0015804; GO:0016323; GO:0046982; GO:0070327,neutral amino acid transport [GO:0015804]; thyroid hormone transport [GO:0070327],antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; protein heterodimerization activity [GO:0046982]; thyroid hormone transmembrane transporter activity [GO:0015349],basolateral plasma membrane [GO:0016323],,,,,,
gene-LOC134683121|LOC134683121,20.3245660388693,0.563339560856423,0.177347226369408,8.51691181915759e-5,0.0159032653895767,LOC134683121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134693841|LOC134693841,337.919838241674,0.453436693579688,0.116720599578759,7.58842072149676e-6,0.00266163856806499,LOC134693841,lcl|NC_086384.1_cds_XP_063410843.1_44345,sp,O43432,IF4G3,HUMAN,41.838,1023,514,15,1939,4899,604,1581,0,687,reviewed,IF4G3_HUMAN,Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII),EIF4G3,Homo sapiens (Human),1585,GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0007286; GO:0008135; GO:0016281; GO:0043232; GO:0045727,positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; spermatid development [GO:0007286]; translational initiation [GO:0006413],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]",cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; intracellular non-membrane-bounded organelle [GO:0043232],,,O43432;,R-HSA-1169408;,,P06730
gene-LOC134706619|LOC134706619,38.3252855319555,1.43250510862426,0.488441527409042,1.14363761012287e-4,0.0159032653895767,LOC134706619,lcl|NC_086374.1_cds_XP_063421783.1_6722,sp,Q5ZJU3,ASNS,CHICK,62.95,556,199,3,1,1647,1,556,0,690,reviewed,ASNS_CHICK,Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase),ASNS RCJMB04_15l3,Gallus gallus (Chicken),561,GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0042149; GO:0043066; GO:0045931; GO:0070981,asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931],asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524],cytosol [GO:0005829],,,,,UPA00134;,
gene-LOC134707958|LOC134707958,97.9832397869829,1.25303731249172,0.213872989545136,2.35011190247543e-10,6.59441399834607e-7,LOC134707958,lcl|NC_086374.1_cds_XP_063424212.1_9673,sp,Q01650,LAT1,HUMAN,39.13,115,70,0,1,345,393,507,1.02e-25,103,reviewed,LAT1_HUMAN,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),SLC7A5 CD98LC LAT1 MPE16,Homo sapiens (Human),507,GO:0002720; GO:0003333; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010507; GO:0010629; GO:0014850; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015297; GO:0015349; GO:0015804; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0015824; GO:0015827; GO:0015828; GO:0015829; GO:0016020; GO:0016323; GO:0016324; GO:0031528; GO:0032328; GO:0032729; GO:0032740; GO:0032753; GO:0042149; GO:0042605; GO:0042908; GO:0043231; GO:0055093; GO:0060252; GO:0070062; GO:0070327; GO:0071222; GO:0089718; GO:0097421; GO:0098591; GO:0150104; GO:1902024; GO:1903577; GO:1903801; GO:1904556; GO:1905460; GO:1905534; GO:1990184,alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; L-tryptophan transmembrane transport [GO:1904556]; liver regeneration [GO:0097421]; methionine transport [GO:0015821]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of L-leucine import across plasma membrane [GO:1905534]; positive regulation of type II interferon production [GO:0032729]; proline transport [GO:0015824]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908],amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349],amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],,"INDUCTION: (Microbial infection) Up-regulation of the complex formed by SLC3A2 and SLC7A5/LAT1 upon hepatitis C virus/HCV infection. {ECO:0000269|PubMed:30341327}.; INDUCTION: Expression induced in quiescent peripheral blood lymphocytes after treatment with phorbol myristate acetate (PMA) and phytohemagglutinin (PHA). Expression and the uptake of leucine is stimulated in mononuclear, cytotrophoblast-like choriocarcinoma cells by combined treatment with PMA and calcium ionophore. {ECO:0000269|PubMed:11742812, ECO:0000269|PubMed:1597461}.",Q01650;,R-HSA-210991;R-HSA-352230;R-HSA-71240;,,P08195; P08195-1
gene-LOC134714392|LOC134714392,50.9975407417056,0.738859171518569,0.279593786857687,3.32420802552747e-4,0.0333199071790098,LOC134714392,lcl|NC_086373.1_cds_XP_063431707.1_416,sp,Q1JPX3,SYFA,DANRE,67.936,499,155,4,1,1491,1,496,0,702,reviewed,SYFA_DANRE,Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS),farsa farsla zgc:136506 zgc:158185,Danio rerio (Zebrafish) (Brachydanio rerio),497,GO:0000049; GO:0000287; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328; GO:0051290,phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049],cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328],,,,,,
gene-LOC134712368|LOC134712368,428.086653096726,0.76000198966035,0.153008411526219,3.69328247366219e-8,4.82948789040085e-5,LOC134712368,lcl|NC_086375.1_cds_XP_063429923.1_14948,sp,Q64319,SLC31,RAT,32.937,589,323,19,163,1839,62,608,3.24e-89,295,reviewed,SLC31_RAT,"Amino acid transporter heavy chain SLC3A1 (D2) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (NAA-TR) (rBAT)",Slc3a1 Nbat,Rattus norvegicus (Rat),683,GO:0005774; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046872; GO:0046982,amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813],metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; vacuolar membrane [GO:0005774],,,,R-RNO-352230;,,
gene-LOC134715440|LOC134715440,37.0144375797174,-0.776820800251853,0.250789332041579,8.53157290935238e-5,0.0159032653895767,LOC134715440,lcl|NC_086376.1_cds_XP_063433685.1_18425,sp,A6QQM4,ZN474,BOVIN,53.175,378,139,6,988,2052,89,451,9.14e-105,330,reviewed,ZN474_BOVIN,Zinc finger protein 474,ZNF474,Bos taurus (Bovine),454,GO:0046872,,metal ion binding [GO:0046872],,,,,,,
gene-LOC134715440|LOC134715440,37.0144375797174,-0.776820800251853,0.250789332041579,8.53157290935238e-5,0.0159032653895767,LOC134715440,lcl|NC_086376.1_cds_XP_063433685.1_18425,sp,A6QQM4,ZN474,BOVIN,45.968,372,171,7,601,1662,90,449,2.72e-90,292,reviewed,ZN474_BOVIN,Zinc finger protein 474,ZNF474,Bos taurus (Bovine),454,GO:0046872,,metal ion binding [GO:0046872],,,,,,,
gene-LOC134715440|LOC134715440,37.0144375797174,-0.776820800251853,0.250789332041579,8.53157290935238e-5,0.0159032653895767,LOC134715440,lcl|NC_086376.1_cds_XP_063433685.1_18425,sp,A6QQM4,ZN474,BOVIN,61.905,105,37,2,4,312,83,186,1.05e-28,123,reviewed,ZN474_BOVIN,Zinc finger protein 474,ZNF474,Bos taurus (Bovine),454,GO:0046872,,metal ion binding [GO:0046872],,,,,,,
gene-LOC134715440|LOC134715440,37.0144375797174,-0.776820800251853,0.250789332041579,8.53157290935238e-5,0.0159032653895767,LOC134715440,lcl|NC_086376.1_cds_XP_063433685.1_18425,sp,A6QQM4,ZN474,BOVIN,59.794,97,38,1,25,312,353,449,5.52e-27,118,reviewed,ZN474_BOVIN,Zinc finger protein 474,ZNF474,Bos taurus (Bovine),454,GO:0046872,,metal ion binding [GO:0046872],,,,,,,
gene-LOC134715440|LOC134715440,37.0144375797174,-0.776820800251853,0.250789332041579,8.53157290935238e-5,0.0159032653895767,LOC134715440,lcl|NC_086376.1_cds_XP_063433685.1_18425,sp,A6QQM4,ZN474,BOVIN,50.962,104,41,3,7,315,212,306,7.88e-23,105,reviewed,ZN474_BOVIN,Zinc finger protein 474,ZNF474,Bos taurus (Bovine),454,GO:0046872,,metal ion binding [GO:0046872],,,,,,,
gene-LOC134680676|LOC134680676,17.716746510177,0.821485148359872,0.345408248531555,6.19526913341295e-4,0.0453177007779924,LOC134680676,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134725135|LOC134725135,39.4059870536042,0.585888712908243,0.208732496373123,2.4234135026614e-4,0.027878559823874,LOC134725135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134710327|LOC134710327,78.2823688145302,0.527315379082503,0.116867650364043,4.32326877717771e-7,2.69579826416903e-4,LOC134710327,lcl|NC_086375.1_cds_XP_063426723.1_11862,sp,P28650,PURA1,MOUSE,63.529,425,149,3,85,1344,33,456,0,565,reviewed,PURA1_MOUSE,"Adenylosuccinate synthetase isozyme 1 (AMPSase 1) (AdSS 1) (EC 6.3.4.4) (Adenylosuccinate synthetase like 1) (Adenylosuccinate synthetase, basic isozyme) (Adenylosuccinate synthetase, muscle isozyme) (M-type adenylosuccinate synthetase) (IMP--aspartate ligase 1)",Adss1 Adssl1,Mus musculus (Mouse),457,GO:0000287; GO:0003924; GO:0004019; GO:0005525; GO:0005737; GO:0006163; GO:0006531; GO:0016020; GO:0042802; GO:0044208; GO:0044209; GO:0046040; GO:0051015,'de novo' AMP biosynthetic process [GO:0044208]; AMP salvage [GO:0044209]; aspartate metabolic process [GO:0006531]; IMP metabolic process [GO:0046040]; purine nucleotide metabolic process [GO:0006163],actin filament binding [GO:0051015]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287],cytoplasm [GO:0005737]; membrane [GO:0016020],,,,R-MMU-73817;,UPA00075;,
gene-LOC134706448|LOC134706448,174.011781818094,0.427035321502536,0.157959495589186,4.55761820323838e-4,0.0388473240862746,LOC134706448,lcl|NC_086374.1_cds_XP_063421467.1_6338,sp,Q99LE6,ABCF2,MOUSE,72.909,550,147,1,211,1860,76,623,0,828,reviewed,ABCF2_MOUSE,ATP-binding cassette sub-family F member 2,Abcf2,Mus musculus (Mouse),628,GO:0005524; GO:0005739; GO:0016887,,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],mitochondrion [GO:0005739],,,,,,
gene-LOC134687007|LOC134687007,30.3186417202937,0.849453813075907,0.282346010596901,1.10497509809607e-4,0.0159032653895767,LOC134687007,lcl|NC_086382.1_cds_XP_063402986.1_37972,sp,O54862,MBTP2,CRIGR,42.799,493,257,4,40,1446,14,505,1.39e-139,414,reviewed,MBTP2_CRIGR,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease) (SREBPs intramembrane protease),MBTPS2 S2P,Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),510,GO:0000139; GO:0004222; GO:0005737; GO:0007095; GO:0008203; GO:0031293; GO:0034976; GO:0045944; GO:0046872; GO:0051604; GO:0061629; GO:0070977; GO:0140537; GO:1905897,bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein maturation [GO:0051604]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to endoplasmic reticulum stress [GO:0034976],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator activator activity [GO:0140537],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139],,,,,,
gene-LOC134728203|LOC134728203,92.7324908596292,0.909488076275419,0.197100666967736,1.95945856112363e-7,1.57092592071797e-4,LOC134728203,lcl|NC_086373.1_cds_XP_063448789.1_2855,sp,P26636,SYSC,CRIGR,70.711,478,138,2,1,1431,1,477,0,715,reviewed,SYSC_CRIGR,"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",SARS1 SARS,Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),512,GO:0000049; GO:0000122; GO:0000978; GO:0001514; GO:0002181; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006434; GO:0016525; GO:0070158; GO:0098619; GO:1904046,cytoplasmic translation [GO:0002181]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteine incorporation [GO:0001514]; seryl-tRNA aminoacylation [GO:0006434],ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; selenocysteine-tRNA ligase activity [GO:0098619]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,,,,UPA00906;,
gene-LOC134705107|LOC134705107,646.759724406012,-0.91129613040122,0.382223734275329,5.58493886389033e-4,0.0429351738413048,LOC134705107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
gene-LOC134721377|LOC134721377,80.2364945659586,0.823052983927141,0.27327335451052,1.09200698926836e-4,0.0159032653895767,LOC134721377,lcl|NC_086378.1_cds_XP_063440410.1_25043,sp,P49588,SYAC,HUMAN,62.668,967,353,3,1,2889,1,963,0,1229,reviewed,SYAC_HUMAN,"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)",AARS1 AARS,Homo sapiens (Human),968,GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0021680; GO:0043524; GO:0050885; GO:0051402; GO:0070062; GO:0140018,alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739],,,P49588;,R-HSA-379716;,,
gene-LOC134706246|LOC134706246,46.5995402719709,0.735633774460437,0.206089144945192,1.77261485367512e-5,0.00497395727941239,LOC134706246,lcl|NC_086374.1_cds_XP_063421085.1_5926,sp,A0A2C9JXL4,C1GLT,BIOGL,59.777,358,138,2,106,1179,34,385,1.92e-159,457,reviewed,C1GLT_BIOGL,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Glycoprotein-N-acetylgalactosamine beta-1,3-galactosyltransferase) (Beta-1,3-galactosyltransferase) (T-synthase)",,Biomphalaria glabrata (Bloodfluke planorb) (Freshwater snail),388,GO:0000166; GO:0006486; GO:0016020; GO:0016263; GO:0030145,protein glycosylation [GO:0006486],glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166],membrane [GO:0016020],,,,,UPA00378;,
gene-LOC134715416|LOC134715416,143.072848201906,0.287840636014165,0.0960862700038158,3.49992425924868e-4,0.0333199071790098,LOC134715416,lcl|NC_086376.1_cds_XP_063433648.1_18390,sp,Q5REX3,ZFR,PONAB,60.714,364,119,4,1681,2772,720,1059,4.63e-125,408,reviewed,ZFR_PONAB,Zinc finger RNA-binding protein,ZFR,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),1074,GO:0003677; GO:0003725; GO:0003727; GO:0005694; GO:0005737; GO:0008270; GO:0071011,,DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],chromosome [GO:0005694]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011],,,,,,
gene-LOC134715416|LOC134715416,143.072848201906,0.287840636014165,0.0960862700038158,3.49992425924868e-4,0.0333199071790098,LOC134715416,lcl|NC_086376.1_cds_XP_063433648.1_18390,sp,Q5REX3,ZFR,PONAB,56.146,301,88,6,688,1464,330,628,7.8e-90,312,reviewed,ZFR_PONAB,Zinc finger RNA-binding protein,ZFR,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),1074,GO:0003677; GO:0003725; GO:0003727; GO:0005694; GO:0005737; GO:0008270; GO:0071011,,DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],chromosome [GO:0005694]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011],,,,,,
gene-LOC134721550|LOC134721550,75.9938588122951,0.521919387328945,0.212327271589639,6.88670857635201e-4,0.0483102606631094,LOC134721550,lcl|NC_086378.1_cds_XP_063440714.1_25501,sp,Q94407,NHR48,CAEEL,56.962,79,32,1,271,501,92,170,1.25e-21,103,reviewed,NHR48_CAEEL,Nuclear hormone receptor family member nhr-48,nhr-48 ZK662.3,Caenorhabditis elegans,817,GO:0000122; GO:0000978; GO:0004879; GO:0005634; GO:0008270; GO:0030154; GO:0045944,cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270],nucleus [GO:0005634],,,,R-CEL-196791;R-CEL-383280;,,
gene-LOC134687647|LOC134687647,66.3632514545797,-0.557606061965116,0.180717036720536,1.102112684205e-4,0.0159032653895767,LOC134687647,lcl|NC_086382.1_cds_XP_063404170.1_39548,sp,Q8TE73,DYH5,HUMAN,27.593,1533,943,30,6202,10707,1764,3160,0,671,reviewed,DYH5_HUMAN,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),DNAH5 DNAHC5 HL1 KIAA1603,Homo sapiens (Human),4624,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,,Q8TE73;,,,
gene-LOC134687647|LOC134687647,66.3632514545797,-0.557606061965116,0.180717036720536,1.102112684205e-4,0.0159032653895767,LOC134687647,lcl|NC_086382.1_cds_XP_063404170.1_39548,sp,Q8TE73,DYH5,HUMAN,31.908,655,443,2,3853,5817,1105,1756,3.52e-89,332,reviewed,DYH5_HUMAN,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),DNAH5 DNAHC5 HL1 KIAA1603,Homo sapiens (Human),4624,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,,Q8TE73;,,,
gene-LOC134687647|LOC134687647,66.3632514545797,-0.557606061965116,0.180717036720536,1.102112684205e-4,0.0159032653895767,LOC134687647,lcl|NC_086382.1_cds_XP_063404170.1_39548,sp,Q8TE73,DYH5,HUMAN,23.231,1145,715,31,12208,15600,3450,4444,8.26e-65,252,reviewed,DYH5_HUMAN,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),DNAH5 DNAHC5 HL1 KIAA1603,Homo sapiens (Human),4624,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,,Q8TE73;,,,
gene-LOC134687647|LOC134687647,66.3632514545797,-0.557606061965116,0.180717036720536,1.102112684205e-4,0.0159032653895767,LOC134687647,lcl|NC_086382.1_cds_XP_063404170.1_39548,sp,Q8TE73,DYH5,HUMAN,31.307,329,214,4,2149,3135,519,835,2.77e-46,191,reviewed,DYH5_HUMAN,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),DNAH5 DNAHC5 HL1 KIAA1603,Homo sapiens (Human),4624,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,,Q8TE73;,,,
gene-LOC134687647|LOC134687647,66.3632514545797,-0.557606061965116,0.180717036720536,1.102112684205e-4,0.0159032653895767,LOC134687647,lcl|NC_086382.1_cds_XP_063404170.1_39548,sp,Q8TE73,DYH5,HUMAN,28.251,446,261,14,1,1233,33,454,3.62e-27,127,reviewed,DYH5_HUMAN,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),DNAH5 DNAHC5 HL1 KIAA1603,Homo sapiens (Human),4624,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,,Q8TE73;,,,
gene-LOC134721694|LOC134721694,106.577179072589,0.552658250062276,0.203136630341766,3.30217678822659e-4,0.0333199071790098,LOC134721694,lcl|NC_086378.1_cds_XP_063440931.1_25868,sp,Q99L45,IF2B,MOUSE,80.588,170,33,0,511,1020,160,329,2.31e-104,312,reviewed,IF2B_MOUSE,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Eif2s2,Mus musculus (Mouse),331,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003729; GO:0003743; GO:0005829; GO:0005850; GO:0008584; GO:0031369; GO:0045202; GO:0046872,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584],metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],,,,R-MMU-156827;R-MMU-381042;R-MMU-382556;R-MMU-72649;R-MMU-72695;R-MMU-72702;R-MMU-72706;R-MMU-72731;R-MMU-9840373;,,
